Dr. Sean Khozin serves as the Chief Executive Officer of the CEO Roundtable on Cancer and Project Data Sphere directing the organizations’ public health programs and pioneering initiatives focused on the development of AI foundation models in oncology. Concurrently, he is the founder of Phyusion Bio and a Research Affiliate at the Massachusetts Institute of Technology, focusing on novel AI applications and machine learning to accelerate drug discovery and optimize therapeutic development strategies.
Previously, Dr. Khozin served as the Chief Executive Officer of CancerLinQ, the Global Head of Data Strategy and Data Science Innovation at Johnson & Johnson, Associate Director at U.S. FDA OCE, and Executive Director of FDA INFORMED.